@vrs37 - you posted that "from what I can see their trial shares lot of similarity with dmx fgs phase 3 trial, like the same endpoints and length"
This is a very different view than that articulated in a recent Investor Presentation in a DXB announcement - where they claimed there is NO comparison with Travere's Duplex trial (see slide below).
I like contrary views that are based on science and logical argument, but I don't like manipulative innuendo.
While not, at this moment, accusing you of the latter, I would like to see your more detailed arguments as to why you are correct and why Dimerix management is not. Unsubstantiated statements or inferences are completely worthless!
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-389
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.2M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 39.0¢ | $192.6K | 489.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 53870 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 329447 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 42820 | 0.390 |
5 | 137940 | 0.385 |
9 | 172528 | 0.380 |
4 | 211736 | 0.375 |
15 | 438581 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 49553 | 7 |
0.400 | 332840 | 5 |
0.405 | 91334 | 6 |
0.410 | 282503 | 6 |
0.415 | 57000 | 3 |
Last trade - 11.31am 09/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online